outlines

Alx Oncology outlines interim ASPEN-09 data from ~80 patients by mid-2027 as CD47-high cohort shows 22-month median PFS (NASDAQ:ALXO)

Earnings Call Insights: ALX Oncology (ALXO) Q1 2026

Management view

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Source link

EHealth outlines 20% fixed cost reduction and targets 20% adjusted EBITDA margin by 2028 as it rolls out lifetime advisory model (NASDAQ:EHTH)

Earnings Call Insights: eHealth (EHTH) Q1 2026

Management view

  • “We’re pleased with our first quarter results, which came in ahead of expectations. driven by stronger-than-anticipated Medicare enrollment volume at favorable unit economics.” (CEO & Director Derrick Duke)
  • “From a financial

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Source link

Exelixis outlines December PDUFA timeline for ZANZA CRC filing while adding $750M buyback authorization (NASDAQ:EXEL)

Earnings Call Insights: Exelixis (EXEL) Q1 2026

Management View

  • Michael Morrissey (CEO, President & Director) said the company’s strategy is “to build a multi-franchise business in solid tumor oncology focused on GU and GI histologies,” anchored by cabozantinib and “the potential breadth of the zanzalitinib opportunity,” and added that “CABOMETYX

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Source link

Live Nation outlines venue strategy targeting up to 30% premium capacity, as it highlights Q3-weighted 2026 growth (NYSE:LYV)

Earnings Call Insights: Live Nation Entertainment (LYV) Q1 2026

Management View

  • Michael Rapino said demand and cancellations were tracking normally, stating, “We always have a few cancellations” and “We tend to have 1% to 2% cancellation rate historically” (President, CEO & Director Michael Rapino).

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Source link